Nyxoah (NYXH) News Today $10.53 +0.15 (+1.45%) As of 01/30/2025 04:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 Time Period Contrasting LeMaitre Vascular (NASDAQ:LMAT) and Nyxoah (NASDAQ:NYXH)January 24, 2025 | americanbankingnews.comPublication relating to transparency notificationsJanuary 20, 2025 | globenewswire.comNyxoah SA Ordinary SharesJanuary 9, 2025 | morningstar.comNyxoah (NASDAQ:NYXH) Stock Price Up 1.2% - Here's What HappenedNyxoah (NASDAQ:NYXH) Stock Price Up 1.2% - Here's What HappenedJanuary 4, 2025 | marketbeat.comNyxoah: The Future Of OSADecember 30, 2024 | seekingalpha.comPublication relating to transparency notificationsDecember 20, 2024 | globenewswire.comNyxoah introduces neurostimulator device for sleep apnoea in EnglandDecember 18, 2024 | msn.comNyxoah’s Strategic Expansion and Market Potential Drive Buy RatingDecember 14, 2024 | markets.businessinsider.comEQS-News: Nyxoah Announces Commercial Launch of Genio® Innovative Therapy in EnglandDecember 13, 2024 | markets.businessinsider.comNyxoah Announces Commercial Launch of Genio® Innovative Therapy in EnglandDecember 13, 2024 | globenewswire.comNyxoah to Present at Healthcare Conference Amidst GrowthNovember 21, 2024 | markets.businessinsider.comNyxoah to Participate in the Piper Sandler 36th Annual Healthcare ConferenceNovember 20, 2024 | globenewswire.comNyxoah’s Voting Rights Shift with ResMed StakeNovember 19, 2024 | markets.businessinsider.comInvitation to attend the special shareholders' meeting of the Company to be held on December 19, 2024November 19, 2024 | globenewswire.comPublication relating to transparency notificationsNovember 18, 2024 | globenewswire.comNyxoah S.A. (NASDAQ:NYXH) Short Interest Down 17.4% in OctoberNyxoah S.A. (NASDAQ:NYXH - Get Free Report) saw a large decline in short interest in October. As of October 31st, there was short interest totalling 58,800 shares, a decline of 17.4% from the October 15th total of 71,200 shares. Approximately 0.4% of the shares of the stock are sold short. Based on an average daily volume of 63,200 shares, the short-interest ratio is currently 0.9 days.November 15, 2024 | marketbeat.comNyxoah S.A. (NYXH) Q3 2024 Earnings Call TranscriptNovember 8, 2024 | seekingalpha.comNyxoah SA (NYXH) Q3 2024 Earnings Call Highlights: Strategic Advances Amid Financial ChallengesNovember 7, 2024 | finance.yahoo.comEQS-News: Nyxoah Reports Third Quarter Financial and Operating ResultsNovember 6, 2024 | markets.businessinsider.comNyxoah SA (NYXH) Q3 2024: Everything You Need To Know Ahead Of EarningsNovember 6, 2024 | finance.yahoo.comNyxoah Strengthens Leadership for U.S. and Global ExpansionNovember 6, 2024 | markets.businessinsider.comCantor Fitzgerald Sticks to Their Buy Rating for Nyxoah (NYXH)November 6, 2024 | markets.businessinsider.comNyxoah Names John Landry as New CFONovember 4, 2024 | marketwatch.comNyxoah Appoints John Landry as Chief Financial OfficerNovember 4, 2024 | globenewswire.comPublication relating to transparency notificationsOctober 25, 2024 | globenewswire.comNyxoah to Announce Q3 2024 Financial ResultsOctober 23, 2024 | markets.businessinsider.comNyxoah to Release Third Quarter 2024 Financial Results on November 6, 2024October 22, 2024 | globenewswire.comPublication relating to transparency notificationsOctober 15, 2024 | globenewswire.comHC Wainwright Trims Nyxoah (NASDAQ:NYXH) Target Price to $17.00HC Wainwright reduced their price target on shares of Nyxoah from $18.00 to $17.00 and set a "buy" rating for the company in a research note on Friday.October 11, 2024 | marketbeat.comAnalysts Offer Insights on Healthcare Companies: Medios AG (OtherMEDOF) and Nyxoah (NYXH)October 10, 2024 | markets.businessinsider.comNyxoah SA (NYXH) Q2 2024 Earnings Call Highlights: Strategic Growth and US Market PreparationsOctober 9, 2024 | finance.yahoo.comPublication relating to transparency notificationsOctober 9, 2024 | globenewswire.comEQS-News: Nyxoah Raises $27 Million through its At-the-Market OfferingOctober 9, 2024 | markets.businessinsider.comNyxoah Secures $27 Million to Boost U.S. PresenceOctober 9, 2024 | finance.yahoo.comNyxoah Raises $27 Million through its At-the-Market OfferingOctober 7, 2024 | globenewswire.comNyxoah S.A. (NYXH.BR)October 6, 2024 | finance.yahoo.comBuy Rating Reiterated for Nyxoah Amid Promising Genio System Performance and Significant Market OpportunitySeptember 30, 2024 | markets.businessinsider.comHC Wainwright Reiterates Buy Rating for Nyxoah (NASDAQ:NYXH)HC Wainwright reaffirmed a "buy" rating and issued a $18.00 target price on shares of Nyxoah in a report on Monday.September 30, 2024 | marketbeat.comCVI Holdings LLC Makes New $1.29 Million Investment in Nyxoah S.A. (NASDAQ:NYXH)CVI Holdings LLC bought a new position in Nyxoah S.A. (NASDAQ:NYXH - Free Report) during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund bought 183,590 shares of the company's stock, valued at approximately $1,292,000. Nyxoah accoSeptember 28, 2024 | marketbeat.comDREAM Pivotal Study Data Presented at the International Surgical Sleep Society 2024 Educational UpdateSeptember 27, 2024 | globenewswire.comPublication relating to transparency notificationsSeptember 27, 2024 | globenewswire.comNyxoah (NASDAQ:NYXH) Stock Price Down 2.1%Nyxoah (NASDAQ:NYXH) Stock Price Down 2.1%September 21, 2024 | marketbeat.comNYXH Nyxoah S.A.September 12, 2024 | seekingalpha.comNyxoah to Participate in Upcoming Investor ConferencesSeptember 5, 2024 | globenewswire.comEQS-News: Nyxoah Rings the Closing Bell at Nasdaq while Preparing for U.S. Market Launch of Innovative Sleep Apnea DeviceSeptember 2, 2024 | markets.businessinsider.comNyxoah Rings the Closing Bell at Nasdaq while Preparing for U.S. Market Launch of Innovative Sleep Apnea DeviceSeptember 2, 2024 | globenewswire.comNyxoah SA Rings the Closing BellSeptember 1, 2024 | nasdaq.comNyxoah S.A. (NASDAQ:NYXH) Short Interest Down 18.8% in AugustNyxoah S.A. (NASDAQ:NYXH - Get Free Report) was the recipient of a significant decrease in short interest in August. As of August 15th, there was short interest totalling 48,000 shares, a decrease of 18.8% from the July 31st total of 59,100 shares. Currently, 0.3% of the shares of the stock are short sold. Based on an average daily trading volume, of 28,100 shares, the short-interest ratio is currently 1.7 days.August 30, 2024 | marketbeat.comFY2024 Earnings Estimate for Nyxoah S.A. (NASDAQ:NYXH) Issued By Cantor FitzgeraldNyxoah S.A. (NASDAQ:NYXH - Free Report) - Analysts at Cantor Fitzgerald decreased their FY2024 earnings per share estimates for shares of Nyxoah in a research report issued on Wednesday, August 7th. Cantor Fitzgerald analyst R. Osborn now anticipates that the company will post earnings per shareAugust 9, 2024 | marketbeat.comBuy Rating Affirmed for Nyxoah on Strong Financial Footing and Promising U.S. Market ProspectsAugust 7, 2024 | markets.businessinsider.com Get Nyxoah News Delivered to You Automatically Sign up to receive the latest news and ratings for NYXH and its competitors with MarketBeat's FREE daily newsletter. Email Address NYXH Media Mentions By Week NYXH Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NYXH News Sentiment▼1.150.71▲Average Medical News Sentiment NYXH News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NYXH Articles This Week▼42▲NYXH Articles Average Week Get Nyxoah News Delivered to You Automatically Sign up to receive the latest news and ratings for NYXH and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Alpha Tau Medical News Today Heart Test Laboratories News Today HeartBeam News Today Innovative Eyewear News Today Inspira Technologies Oxy B.H.N. News Today Spectral AI News Today Stevanato Group News Today TriSalus Life Sciences News Today GE HealthCare Technologies News Today Koninklijke Philips News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:NYXH) was last updated on 1/31/2025 by MarketBeat.com Staff From Our Partners Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored#1 Crypto of 2025Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode in 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe crypto bull market is here, and the stakes couldn’t be higher. The next 3-6 months? They’re the most ex...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nyxoah S.A. Please log in to your account or sign up in order to add this asset to your watchlist. Share Nyxoah With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free NYXH Stock Alerts